ClassID:

94524

C07D239/93 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems; Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4 Sulfur atoms

Recent Application in this class:
#1
20230159446
2023-05-25

Methods and Compositions for Targeting Tregs using CCR8 Inhibitors

#2
20230103791
2023-04-06

2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS

#3
20200216469
2020-07-09

Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies

#4
20200129512
2020-04-30

NOVEL ANTI-INFLAMMATORY AGENTS

#5
20190112317
2019-04-18

ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES

#6
20180319818
2018-11-08

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#7
20180312527
2018-11-01

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#8
20180312526
2018-11-01

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#9
20170326143
2017-11-16

NOVEL ANTI-INFLAMMATORY AGENTS

#10
20170210759
2017-07-27

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#11
20160297775
2016-10-13

Quinazoline derivatives as TAM family kinase inhibitors

#12
20160199375
2016-07-14

RAF kinase modulator compounds and methods of use thereof

#13
20150246042
2015-09-03

RAF kinase modulator compounds and methods of use thereof

#14
20140350033
2014-11-27

Ant-ligands molecules and biological applications

#15
20140045868
2014-02-13

RAF kinase modulator compounds and methods of use thereof

#16
20130303767
2013-11-14

Thionating agent

#17
20130178624
2013-07-11

Quinazoline derivatives

#18
20130102774
2013-04-25

Thionation process and a thionating agent

#19
20120258975
2012-10-11

Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof

#20
20120122902
2012-05-17

Pyrimidine derivative, preparation method and use thereof

#21
20120059002
2012-03-08

Anti-inflammatory agents

#22
20110224155
2011-09-15

Modulation of chemosensory receptors and ligands associated therewith

#23
20110118245
2011-05-19

RAF kinase modulator compounds and methods of use thereof

#24
20110086865
2011-04-14

ANT-ligands molecules and biological applications

#25
20110034472
2011-02-10

Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function

#26
20100189648
2010-07-29

INHIBITORS FOR DISRUPTING THE INTERACTION OF UBIQUITINATION RELATED ENZYMES AND USES THEREOF

#27
20100125139
2010-05-20

PROCESS FOR PREPARING QUINAZOLINE RHO-KINASE INHIBITORS AND INTERMEDIATES THEREOF

#28
20100105668
2010-04-29

Quinazoline derivatives

#29
20100063075
2010-03-11

Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives

#30
20090312322
2009-12-17

Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3

#31
20090093489
2009-04-09

NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION

#32
20080207614
2008-08-28

QUINAZOLINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES AND OBESITY

#33
20060247237
2006-11-02

Macrocyclic quinazoline derivatives as antiproliferative agents

#34
20060235034
2006-10-19

Novel compounds for treatment of cancer and disorders associated with angiogenesis function

#35
20060079685
2006-04-13

Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives

#36
20050107321
2005-05-19

Cell line comprising vector encoding truncated FLK-1 receptor

#37
20050070559
2005-03-31

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3